Back to Trials
NCT01885299Recruiting

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

The Radiosurgery Society

Start Date

3/1/2012

Completion Date

12/1/2030

Summary

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Detailed Description

The Registry is designed to help SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) users to understand utilization of and key treatment outcomes for these treatment approaches. Some of the objectives include: Allow participants to record information about usage of SRS/SBRT in everyday practice, including patient characteristics and disease information, treatment plans and outcomes Provide participants with ready access to data for publication of their own experience and as a tool for establishing collaborations with other participating sites Facilitate quality improvement efforts for individual treatment providers Understand the effectiveness of different treatment plans for different types of lesions, diseases and treatments The Registry tracks select outcomes for each condition treated by SRS/SBRT (for example, PSA for prostate cancer); the Registry also provides individual participants the ability to add additional outcomes for each and any condition of specific interest to their institutions. The Registry is hosted by Vision Tree, Inc who is an independent vendor of electronic registries; they are responsible for HIPAA compliance, including all security mechanisms. Patients will be enrolled prospectively. Some retrospective patient data is likely to be included in order to capture both short and longer term outcomes data.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy * Willingness to sign an Informed Consent Document or verbally agree to participation Exclusion Criteria: * There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

Interventions

RADIATION

SRS/SBRT

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

NeoplasmsArteriovenous Malformation of Central Nervous SystemTrigeminal Neuralgia

Locations

Penrose Cancer Center

Colorado Springs, Colorado 80907

United States

Sylvester Comprehensive Cancer Center, University of Miami

Miami, Florida 33146

United States

Southeast Georgia Health System

Brunswick, Georgia 31520

United States

Henry Ford Health System

Detroit, Michigan 48202

United States

AtlantiCare Regional Medical Center and AtlantiCare Cancer Care Institute

Egg Harbor, New Jersey 08234

United States

Riverview Medical Center

Red Bank, New Jersey 07701

United States

NJ Cyberknife at Community Medical Center

Toms River, New Jersey 08755

United States

Montefiore Medical Center

The Bronx, New York 10502

United States

Geisinger Health System

Danville, Pennsylvania 17822

United States

Philadelphia CyberKnife

Philadelphia, Pennsylvania 19083

United States

Pottstown Memorial Medical Center

Pottstown, Pennsylvania 19464

United States

Cyberknife at Erlanger

Chattanooga, Tennessee 37403

United States

St. Mary's Medical Center

Huntington, West Virginia 25701

United States